Suppr超能文献

亚型选择性的 K2 通道正变构依赖于 HA/ HB 螺旋。

Subtype-selective positive modulation of K 2 channels depends on the HA/HB helices.

机构信息

Department of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Irvine, California, USA.

Department of Pharmaceutical Sciences, Northeastern University School of Pharmacy, Boston, Massachusetts, USA.

出版信息

Br J Pharmacol. 2022 Feb;179(3):460-472. doi: 10.1111/bph.15676. Epub 2021 Oct 1.

Abstract

BACKGROUND AND PURPOSE

In the activated state of small-conductance Ca -activated potassium (K 2) channels, calmodulin interacts with the HA/HB helices and the S4-S5 linker. CyPPA potentiates K 2.2a and K 2.3 channel activity but not the K 2.1 and K 3.1 subtypes.

EXPERIMENTAL APPROACH

Site-directed mutagenesis, patch-clamp recordings and in silico modelling were utilised to explore the structural determinants for the subtype-selective modulation of K 2 channels by CyPPA.

KEY RESULTS

Mutating residues in the HA (V420) and HB (K467) helices of K 2.2a channels to their equivalent residues in K 3.1 channels diminished the potency of CyPPA. CyPPA elicited prominent responses on mutant K 3.1 channels with an arginine residue in the HB helix substituted for its equivalent lysine residue in the K 2.2a channels (R355K). K 2.1 channels harbouring a three-amino-acid insertion upstream of the cognate R438 residues in the HB helix showed no response to CyPPA, whereas the deletion mutant (K 2.1_ΔA434/Q435/K436) became sensitive to CyPPA. In molecular dynamics simulations, CyPPA docked between calmodulin C-lobe and the HA/HB helices widens the cytoplasmic gate of K 2.2a channels.

CONCLUSION AND IMPLICATIONS

Selectivity of CyPPA among K 2 and K 3.1 channel subtypes relies on the HA/HB helices.

摘要

背景与目的

在小电导钙激活钾(K 2 )通道的激活状态下,钙调蛋白与 HA/HB 螺旋和 S4-S5 连接子相互作用。CyPPA 增强 K 2.2a 和 K 2.3 通道的活性,但不增强 K 2.1 和 K 3.1 亚型。

实验方法

利用定点突变、膜片钳记录和计算机建模来探讨 CyPPA 对 K 2 通道亚型选择性调节的结构决定因素。

主要结果

将 K 2.2a 通道的 HA(V420)和 HB(K467)螺旋中的残基突变为 K 3.1 通道中的等效残基,降低了 CyPPA 的效力。CyPPA 在突变的 K 3.1 通道上引起明显的反应,其 HB 螺旋中的精氨酸取代了 K 2.2a 通道中相应的赖氨酸(R355K)。在 HB 螺旋中,K 2.1 通道上游的三个氨基酸插入使 R438 残基失去了对 CyPPA 的反应,而缺失突变体(K 2.1_ΔA434/Q435/K436)对 CyPPA 变得敏感。在分子动力学模拟中,CyPPA 在钙调蛋白 C 结构域和 HA/HB 螺旋之间结合,使 K 2.2a 通道的细胞质门变宽。

结论和意义

CyPPA 在 K 2 和 K 3.1 通道亚型之间的选择性依赖于 HA/HB 螺旋。

相似文献

引用本文的文献

6
Loss-of-function K2.2 mutations abolish channel activity.功能丧失性 K2.2 突变会使通道失活。
Am J Physiol Cell Physiol. 2023 Mar 1;324(3):C658-C664. doi: 10.1152/ajpcell.00584.2022. Epub 2023 Jan 30.
7
Ca-Sensitive Potassium Channels.钙敏钾通道。
Molecules. 2023 Jan 16;28(2):885. doi: 10.3390/molecules28020885.
8
Subtype-Selective Positive Modulation of K2.3 Channels Increases Cilia Length.亚型选择性正向调节 K2.3 通道可增加纤毛长度。
ACS Chem Biol. 2022 Aug 19;17(8):2344-2354. doi: 10.1021/acschembio.2c00469. Epub 2022 Aug 10.
9
Channelopathy of small- and intermediate-conductance Ca-activated K channels.小电导和中等电导钙激活钾通道的通道病。
Acta Pharmacol Sin. 2023 Feb;44(2):259-267. doi: 10.1038/s41401-022-00935-1. Epub 2022 Jun 17.

本文引用的文献

4
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels.《药理学 2019/20 简明指南:离子通道》
Br J Pharmacol. 2019 Dec;176 Suppl 1(Suppl 1):S142-S228. doi: 10.1111/bph.14749.
6
Pharmacology of Small- and Intermediate-Conductance Calcium-Activated Potassium Channels.小电导和中等电导钙激活钾通道的药理学。
Annu Rev Pharmacol Toxicol. 2020 Jan 6;60:219-240. doi: 10.1146/annurev-pharmtox-010919-023420. Epub 2019 Jul 23.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验